×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [16]
中国医学科学院 北... [14]
复旦大学上海医学院 [5]
合肥物质科学研究院 [5]
兰州大学 [4]
吉林大学白求恩第一医... [4]
更多...
内容类型
期刊论文 [61]
会议论文 [4]
发表日期
2022 [2]
2021 [1]
2020 [2]
2019 [6]
2018 [12]
2017 [8]
更多...
学科主题
701.1 elec... [1]
Engineerin... [1]
Nanoscienc... [1]
Physics, A... [1]
electricit... [1]
electricit... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共65条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES)
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:
Cheng, Y.
;
Wu, L.
;
Huang, D. Z.
;
Wang, Q. M.
;
Fan, Y.
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
Trilaciclib
SCLC
Myelopreservation
CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis
期刊论文
Molecular Cancer, 2022, 卷号: 21
作者:
Hua,Jinghan
;
Wang,Xiaolin
;
Ma,Liying
;
Li,Jingxin
;
Cao,Guozhen
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/22
CircVAPA
SCLC
Progression
miR-377-3p
miR-494-3p
IGF1R
AKT
BMS-536924
Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective
期刊论文
TUMORI JOURNAL, 2021
作者:
Tong, Ying-hui
;
Ding, Hai-ying
;
Xin, Wen-xiu
;
Zhong, Li-ke
;
Xu, Gao-qi
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2021/08/30
Cost-effectiveness
durvalumab
etoposide plus platinum chemotherapy
first-line treatment
SCLC
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 卷号: 39
作者:
Ma, Liying
;
Bian, Xing
;
Lin, Wenchu
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2020/11/30
SCLC
PI3K
HDAC
CUDC-907
PARP1
Olaparib
DSB repair
Combination treatment
Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report
期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2020, 卷号: 9
作者:
Zhou, Qinfei
;
Zhao, Jiazheng
;
Wang, Jie
;
Bao, Guanai
;
Gong, Li-Yan
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/11/26
Small-cell lung cancer (SCLC)
immunotherapy
durvalumab
third-line treatment
case report
Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 16
作者:
Wang, Xin
;
Lu, Jie
;
Teng, Feifei
;
Yu, Jinming
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
Limited-stage small cell lung cancer (LS-SCLC)
radiotherapy (RT)
chemoradiation therapy (CRT)
accelerated hyperfractionation
lymphopenia
absolute lymphocyte count (ALC)
Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer
期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 卷号: 12
作者:
Tian, Yaru
;
Zhai, Xiaoyang
;
Han, Anqin
;
Zhu, Hui
;
Yu, Jinming
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/11
SCLC
Immune checkpoint blockades
Immune escape mechanisms
Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 16
作者:
Wang, Xin
;
Lu, Jie
;
Teng, Feifei
;
Yu, Jinming
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
Limited-stage small cell lung cancer (LS-SCLC)
radiotherapy (RT)
chemoradiation therapy (CRT)
accelerated hyperfractionation
lymphopenia
absolute lymphocyte count (ALC)
Building and Validating a Lymphocyte Nadir Based Model to Predict Survival in Patients with Limited Stage-Small Cell Lung Cancer
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 10, 页码: S813-S813
作者:
Yu, Y.
;
Wang, L.
;
Fu, P.
;
Cao, S.
;
Wang, W.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/11
LS-SCLC
lymphocyte nadir
overall survival
Application of prophylactic cranial irradiation in limited-stage small-cell lung cancer: which patients could benefit?
期刊论文
FUTURE ONCOLOGY, 2019, 卷号: 15, 期号: 1, 页码: 3237-3245
作者:
Kou, Peisi
;
Wang, Haiyong
;
Yang, Daoke
;
Zhang, Yan
;
Yu, Jinming
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
LS-SCLC
PCI
prognostic factors
SEER
survival
©版权所有 ©2017 CSpace - Powered by
CSpace